Biolidics Limited reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SGD 0.077 million compared to SGD 1.04 million a year ago. Net loss was SGD 0.94 million compared to SGD 6.21 million a year ago.

Basic loss per share from continuing operations was SGD 0.0016 compared to SGD 0.0188 a year ago. Diluted loss per share from continuing operations was SGD 0.0016 compared to SGD 0.0188 a year ago.